Spectrophotometric microdetermination of anti-Parkinsonian and antiviral drug amantadine HCl in pure and in dosage forms

Abstract

Two simple, rapid, sensitive, low-cost, and accurate methods (A and B) for the microdetermination of amantadine HCl (AMD) in pure form and in pharmaceutical formulations are developed. Method A is based on the formation of tris (o-phenanthroline)-iron(II) complex (ferroin) upon reaction of amantadine HCl with an iron (III)-o-phenanthroline mixture in sodium acetate-acetic acid buffer media. The ferroin complex is spectrophotometrically measured at λmax 509nm against reagent blank. Method B is based on the reduction of Fe (III) by the drug which forms colored complex (λmax 521nm) with 2,2′-bipyridyl. Optimizations of the experimental conditions are described. Beer’s law is obeyed in the concentration ranges 0.4–10 and 0.6–22μgmL−1 using 1,10-phenanthroline and 2,2′-bipyridyl, respectively. The developed methods have been successfully applied for the determination of AMD in bulk drugs and in pharmaceutical formulations. The common excipients and additives did not interfere in their determinations.